Caffeic Acid Phenethyl Ester
CAS 104594-70-9
Caffeic Acid Phenethyl Ester (CAS 104594-70-9) is a pharmaceutical compound with 8 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 19694.402857142857 nM | 105 | - |
| - | Potency | 17792.25581395349 nM | 88 | - |
| - | EC50 | 13466.368421052632 nM | 19 | - |
| - | AC50 | 23995.666666666668 nM | 3 | - |
| - | Ki | 2020.6666666666667 nM | 3 | - |
| - | MIC | 37.5 ug.mL-1 | 2 | - |
| - | IC50 | 0.068 ug.mL-1 | 1 | - |
| - | MIC | 1000 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Caffeic Acid Phenethyl Ester used for in pharmaceutical contexts?
Caffeic Acid Phenethyl Ester (CAS 104594-70-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Caffeic Acid Phenethyl Ester?
No adverse-event association or SIDER side-effect rows are rendered for Caffeic Acid Phenethyl Ester in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Caffeic Acid Phenethyl Ester also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Phenethyl Caffeate with EU status "permitted".
What clinical phase is Caffeic Acid Phenethyl Ester in?
No phase 1-4 clinical development badge is rendered for Caffeic Acid Phenethyl Ester because the matched compound identifier rows do not contain a max-phase value.